Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|May 6, 1998
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) studyE Bajetta, M Di Bartolomeo, C Carnaghi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2011
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancerD Amadori, C Milandri, G Comella, et al.
Oncology Reports|January 12, 2005
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urotheliumVito Lorusso, Enrico Crucitta, Nicola Silvestris, et al.
Oncology|November 29, 2008
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trialS Pignata, G Scambia, A Savarese, et al.
Anticancer Research|March 26, 2002
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II studyC Gridelli, C Curcio, R V Iaffaioli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practiceV Gebbia, E Maiello, F Giuliani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2007
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)F De Vita, F Giuliani, M Orditura, et al.
Cancer Immunology, Immunotherapy : CII|November 26, 1998
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2G Mantovani, V Gebbia, M Airoldi, et al.
Tumori|August 12, 2000
5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: a phase II randomized trialA Sdrobolini, A Contu, B Massidda, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2001
Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trialS Palmeri, V Leonardi, V Gebbia, et al.
Pageof 12